A Step Forward in Building Functional Human Tissues

Toward the ultimate goal of engineering human tissues and organs that can mimic native function for use in drug screening, disease modeling, and regenerative medicine, a Wyss Institute team led by Core Faculty member Jennifer Lewis, Sc.D., has made another foundational advance using three-dimensional (3D) bioprinting. This work builds upon their demonstrated ability to bioprint tissue constructs composed of multiple types of living cells patterned alongside a vascular network in an extracellular matrix. The Wyss team has also previously shown that these constructs could be scaled up to create thick, vascularized tissue constructs, sustained viable for more than a month in vitro. Now, in close collaboration with Roche scientist Annie Moisan, they have leveraged their bioprinting and materials expertise to construct a functional 3D renal architecture containing living human epithelial cells, which line the surface of tubules in the kidney. The study appears online in the journal Scientific Reports.

"The current work further expands our bioprinting platform to create functional human tissue architectures with both technological and clinical relevance," said Lewis, who is also the Hansjörg Wyss Professor of Biologically Inspired Engineering at the Harvard John A. Paulson School of Engineering and Applied Sciences.

The 3D renal architecture created by Lewis' team mimics a proximal tubule, a serpentine hollow tube that is an essential part of each nephron. Every human kidney has over one million nephrons, which perform the vital function of transferring components between blood and urine. Inside the convolutions of a nephron's proximal tubules, 65-80% of nutrients are reabsorbed and transported from the renal filtrate back into the bloodstream. Therefore, the bioprinted 3D renal architecture recapitulates a very small - yet critical - subunit of a whole kidney.

Lewis' team achieved this advance by adapting their earlier approach for bioprinting living cells to form thick tissues. Using a customizable, 3D-printed silicone gasket as a mold, they begin by casting an engineered extracellular matrix as a base layer. Next, a "fugitive ink" (which is eventually liquefied and removed from the final architecture) is printed in a convoluted, winding tubular shape similar to the structure of natural renal proximal tubules. This printed feature is then encapsulated with another layer of extracellular matrix.

Finally, the entire construct is cooled, the fugitive ink is removed, and the result is an open tubule embedded within extracellular matrix. A single inlet and outlet on opposite ends of the tubule are first perfused with cell growth medium and then human proximal tubule cells, which quickly begin to adhere to the lining of the open channel. Eventually, these cells orient into a tightly packed monolayer that lines the entire length of the 3D renal architecture and acts as a cell barrier between the inner lumen of the tubule and the extracellular matrix outside. Nutrients, which perfuse the tubule through the inlet and outlet, nourish the living cells and a keep them alive and functional for more than two months. As the cells mature, the 3D renal architecture begins to perform the same important duties as a natural nephron's proximal tubule. Drugs or other factors can be pumped through the 3D renal architecture to investigate their nephrotoxicity and overall effects on the proximal tubule cells.

Co-first authors of the study Kimberly Homan, Ph.D., a Wyss Research Associate, and David Kolesky, Ph.D., a Wyss Postdoctoral Fellow, stress that the most exciting aspect of the work is that - far beyond mimicking the form of the kidney's proximal tubule -it is a credible in vitro model that functions like living kidney tissue, representing a significant advance from traditional 2D cell culture. The team devoted great effort to characterizing the structure and biological function of the model.

As a result, their approach could one day be scaled up and translated into an implant or organ-assistive device. In the near term, it may offer clinicians a patient-specific tool for assessing treatment options or diagnosing diseases and also give the pharmaceutical industry a powerful way to determine how drugs impact the health and function of the kidney's nephrons.

"The use of functional tissue-like models during pre-clinical studies will provide unprecedented insights into human-relevant drug response prior to clinical development," said Moisan, a Laboratory Head in Mechanistic Safety at Roche and author of this study.

As a fabrication platform, the approach is flexible, scalable, and adaptable, meaning that in addition to working towards larger, scaled-up kidney constructs, the team also plans to explore development of other types of complex functional human tissues and organs.

"We have initially targeted this renal architecture, because the kidney represents such a pressing clinical need across the world," said Lewis. "While thus far we have merely demonstrated a functioning subunit within the kidney, we are actively scaling up the method and its complexity to enable future in vivo applications."

"This advance in 3D printing of living tissues that recapitulate crucial organ functions by Jennifer and her team opens a new path to engineering model systems for drug development, as well as for creating more functional extracorporeal devices and whole organ implants in the future," said Donald Ingber, M.D., Ph.D., Founding Director of the Wyss Institute, Judah Folkman Professor of Vascular Biology at Harvard Medical School and Boston Children's Hospital, and Professor of Bioengineering at SEAS.

The work was funded by the Wyss Institute, the Roche Postdoctoral Fellowship program, National Science Foundation EAGER, and private donations from the GETTY LAB and Dr. Stan Lindenfield.

Homan KA, Kolesky DB, Skylar-Scott MA, Herrmann J, Obuobi H, Moisan A, Lewis JA.
Bioprinting of 3D Convoluted Renal Proximal Tubules on Perfusable Chips.
Sci Rep. 2016 Oct 11;6:34845. doi: 10.1038/srep34845.

Most Popular Now

People may Trust Computers more than Hum…

Despite increasing concern over the intrusion of algorithms in daily life, people may be more willing to trust a computer program than their fellow humans, especially if a task becomes...

Alcidion Acquires UK Patient Flow Softwa…

Smart health technology provider Alcidion Group has today announced the strategic acquisition of ExtraMed, a UK company which specialises in providing NHS trusts with software that helps frontline staff make...

Microsoft Accelerates Industry Cloud Str…

Microsoft Corp (Nasdaq: MSFT) and Nuance Communications, Inc. (Nasdaq: NUAN) have entered into a definitive agreement under which Microsoft will acquire Nuance for $56.00 per share, implying a 23% premium...

Expediting the Diagnosis of Heart Attack…

Siemens Healthineers announced today the company's Atellica VTLi Patient-Side Immunoassay Analyzer(1) has obtained CE mark and is expected to be available later this spring. The Atellica VTLi analyzer provides lab...

New AI Tool Tracks Evolution of COVID-19…

A new machine-learning program accurately identifies COVID-19-related conspiracy theories on social media and models how they evolved over time - a tool that could someday help public health officials combat...

Siemens Healthineers Completes Acquisiti…

Siemens Healthineers AG (Frankfurt: SHL) announced that it has successfully completed the acquisition of Varian Medical Systems, Inc. ("Varian"). The acquisition was previously announced on August 2, 2020. "With Varian, Siemens...

Talking Health Tech

Opinion Article by Andy Kinnear, Partnerships Director, Ethical Healthcare Consulting. Ethical is different. The guy who founded it, [chief executive] Thomas Webb, comes from an NHS background and he is very...

Commission Opens First European Innovati…

Following the launch of the European Innovation Council (EIC) and the announcement of the first funding opportunities, today the Commission opened the first EIC Accelerator calls. The funding worth over...

Artificial Intelligence Model Predicts w…

The human immune defense is based on the ability of white blood cells to accurately identify disease-causing pathogens and to initiate a defense reaction against them. The immune defense is...

Call for Papers: DigiHealthDay-2021

12 November 2021 The DigiHealthDay 2021 is an International Symposium with the theme "Global Digital Health - Today, Tomorrow, and Beyond". The abstracts pertaining to the field of digital health and...

International Master in Digital Health i…

The Master of Digital Health, MDH (formerly - Master of Medical Informatics, MMI) at European Campus Rottal-Inn (ECRI) - a branch of the Deggendorf University of Applied Sciences (DIT) in Bavaria...

Proposal for a Regulation Laying Down Ha…

Artificial Intelligence (AI) is a fast evolving family of technologies that can bring a wide array of economic and societal benefits across the entire spectrum of industries and social activities...